(Q43921912)

28 November 2017

title

Chronic administration of antipsychotics attenuates ongoing and ketamine-induced increases in cortical γ oscillations (English)

1 reference

28 November 2017

3

1 reference

28 November 2017

4

1 reference

28 November 2017

Paul M Anderson

1

0 references

Didier Pinault

object named as

Didier Pinault

series ordinal

2

0 references

publication date

25 June 2014

1 reference

The International Journal of Neuropsychopharmacology

28 November 2017

published in

1 reference

28 November 2017

volume

17

1 reference

28 November 2017

issue

11

1 reference

28 November 2017

page(s)

1895-1904

1 reference

Antipsychotic compounds differentially modulate high-frequency oscillations in the rat nucleus accumbens: a comparison of first- and second-generation drugs.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Steady state and induced auditory gamma deficits in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Acute administration of typical and atypical antipsychotics reduces EEG γ power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in γ power

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

A metabotropic glutamate receptor agonist DCG-IV suppresses synaptic transmission at mossy fiber pathway of the guinea pig hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Gamma oscillations correlate with working memory load in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Effects of antipsychotic treatment on cognition in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Human EEG gamma oscillations in neuropsychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

The neuropathology of schizophrenia. A critical review of the data and their interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Dysfunctional long-range coordination of neural activity during Gestalt perception in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Gamma oscillations in human primary somatosensory cortex reflect pain perception

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy: a [(123)I]CNS-1261 SPET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Left auditory cortex gamma synchronization and auditory hallucination symptoms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Neural synchrony indexes disordered perception and cognition in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Reduced oscillatory gamma-band responses in unmedicated schizophrenic patients indicate impaired frontal network processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Reviewing the ketamine model for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Increased absolute magnitude of gamma synchrony in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Psychomotor, Cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Dynamic predictions: oscillations and synchrony in top-down processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Fluctuation of gamma-band phase synchronization within the auditory cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Contribution of hippocampal region CA3 to consciousness and schizophrenic hallucinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Electrophysiological correlates of flicker-induced color hallucinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

"Gamma (40 Hz) phase synchronicity" and symptom dimensions in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Ketamine modulates theta and gamma oscillations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Gamma frequency-range abnormalities to auditory stimulation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Opposite effects of ketamine and deep brain stimulation on rat thalamocortical information processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

Induced gamma-band activity during the delay of a visual short-term memory task in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

7 January 2021

“Gamma Synchrony” in First-Episode Schizophrenia: A Disorder of Temporal Connectivity?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

7 January 2021

Abnormal neural synchrony in schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

7 January 2021

Metabotropic glutamate receptor-mediated presynaptic depression at corticostriatal synapses involves mGLuR2 or 3

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

7 January 2021

Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000959

7 January 2021

10.1017/S1461145714000959

Identifiers

DOI

1 reference

28 November 2017

1 reference